Johnson & Johnson (JNJ)

Jan 17, 2025, 10:00 AM EST - 14 hours ago

Johnson & Johnson (JNJ) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Jan 16, 2025, 11:29 AM EST - 1 day ago

Johnson & Johnson: Q4 Earnings May Not Prompt Sustained Directional Moves

Jan 16, 2025, 10:00 AM EST - 1 day ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Johnson & Johnson (JNJ) And Encourages Investors to Connect

Jan 16, 2025, 7:30 AM EST - 1 day ago

The Near-Perfect Dividend Portfolio With 10 Sleep-Well-At-Night Gems

ABT DHR ICE LMT MCD MSFT NOC

Jan 16, 2025, 6:14 AM EST - 1 day ago

U.S. Cancer Biopsy Market and Competition Analysis, 2025-2030, Featuring Key Players - BD, IZI Medical Products, Johnson & Johnson Services, Argon Medical Devices, Spectra Medical Devices & More

Jan 15, 2025, 12:39 PM EST - 2 days ago

Buy 3 'Safer' Dividend Kings Of 25 From 53 For January

ADM AWR BKH CWT ED FRT FTS

Jan 15, 2025, 10:00 AM EST - 2 days ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Johnson & Johnson (JNJ) And Encourages Stockholders to Connect

Jan 15, 2025, 8:00 AM EST - 2 days ago

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer

Jan 14, 2025, 4:31 PM EST - 3 days ago

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

AMZN LLY DXCM GSK MRNA NVDA TDOC

Jan 14, 2025, 10:00 AM EST - 3 days ago

Johnson & Johnson (JNJ) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jan 14, 2025, 6:00 AM EST - 3 days ago

7 Blue Chip Dividend Stocks I Used To Build My First $100K Portfolio

CVX JPM MSFT PEP PG SCHD SPY

Jan 13, 2025, 8:00 PM EST - 4 days ago

Healthcare sector poised for rebound in 2025

GSK LLY XLV

Jan 13, 2025, 6:38 PM EST - 4 days ago

INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI

ITCI

Jan 13, 2025, 6:10 PM EST - 4 days ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

Jan 13, 2025, 4:27 PM EST - 4 days ago

Johnson & Johnson (JNJ) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Jan 13, 2025, 3:13 PM EST - 4 days ago

Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal

ITCI

Jan 13, 2025, 1:06 PM EST - 4 days ago

Dean Omar Branham Shirley's Partners Named to List of 500 Leading Lawyers in America

Jan 13, 2025, 12:07 PM EST - 4 days ago

Drugmakers rush to sign deals on first day of industry conference

ABBV GSK ITCI LLY

Jan 13, 2025, 10:03 AM EST - 4 days ago

Like Bristol-Myers Squibb And AbbVie, Johnson & Johnson Seeks To Bolster Neuropsychiatric Portfolio With $15 Billion Deal

ITCI

Jan 13, 2025, 10:00 AM EST - 4 days ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Johnson & Johnson (JNJ) and Encourages Stockholders to Learn More About the Investigation

Jan 13, 2025, 7:13 AM EST - 4 days ago

Johnson & Johnson makes $15 billion bet on mental-health drugs

Jan 13, 2025, 6:38 AM EST - 4 days ago

J&J to buy Intra-Cellular Therapies for $14.6 billion

ITCI

Jan 12, 2025, 4:35 PM EST - 5 days ago

J&J explores bid for Intra-Cellular Therapies, Bloomberg News reports

ITCI

Jan 12, 2025, 10:00 AM EST - 5 days ago

Bronstein, Gewirtz & Grossman, LLC Encourages Johnson & Johnson (JNJ) Investors to Inquire about Securities Investigation

Jan 11, 2025, 6:36 AM EST - 6 days ago

Johnson & Johnson Could Serve As High-Yield Bond Alternative

Jan 10, 2025, 1:15 PM EST - 7 days ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Johnson & Johnson (JNJ) And Encourages Investors to Reach Out

Jan 10, 2025, 11:19 AM EST - 7 days ago

What To Expect From JNJ Stock In 2025?

Jan 9, 2025, 8:04 AM EST - 8 days ago

Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis

Jan 8, 2025, 2:24 PM EST - 9 days ago

J&J pauses rollout of heart device in the US to investigate stroke risk

Jan 8, 2025, 12:13 PM EST - 9 days ago

Dividend Roundup: Why I Prefer Johnson & Johnson Over Pfizer

Jan 8, 2025, 8:00 AM EST - 9 days ago

Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease

Jan 7, 2025, 10:28 PM EST - 10 days ago

Johnson & Johnson: A Potential Beneficiary Of A Great Rotation

Jan 7, 2025, 3:32 PM EST - 10 days ago

Buy 1 January S&P 500 Dividend Aristocrat Out Of 38 'Safer'

ADM AMCR APD BEN CVX FRT HRL

Jan 7, 2025, 11:00 AM EST - 10 days ago

Johnson & Johnson: I'm Saying Yes To This Mess

Jan 7, 2025, 10:59 AM EST - 10 days ago

J&J says its lung cancer drug combination keeps people alive longer

Jan 7, 2025, 8:10 AM EST - 10 days ago

J&J's combo extends patients' lives in head-to-head study with AstraZeneca's drug

AZN

Jan 7, 2025, 8:00 AM EST - 10 days ago

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show statistically significant and clinically meaningful improvement in overall survival versus osimertinib

Jan 6, 2025, 6:00 PM EST - 11 days ago

My Top 10 Dividend Paying Buy-And-Hold Stocks For 2025

AAPL BLK GOOG GOOGL MO MSFT NKE

Jan 4, 2025, 11:49 AM EST - 13 days ago

Big Blue Chip Dividends? Try These ‘Dogs' Up To 6.8%

AMGN CSCO CVX IBM KO MCD MRK

Jan 4, 2025, 8:00 AM EST - 13 days ago

5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 8% (January 2025)

ADM ADP AES AMCR AMH ARCC ATO

Jan 2, 2025, 12:21 PM EST - 15 days ago

January Dow Dogs: 1 'Safer' Buy, And 5 With Promise

AMGN BA CRM CSCO CVX DIS GS